Angiopoietin-like 4

Angiopoietin-like 4 Overview

English NameAngiopoietin-related protein 4Approved Drugs0
Drugs in Clinical Trials3Target SynonymAngiopoietin-like protein 4,Hepatic fibrinogen/angiopoietin-related protein,HFARP,ARP4,PGAR,PP1158,PSEC0166,UNQ171/PRO197,Angiopoietin Like 4,Hepatic Fibrinogen/Angiopoietin-Related Protein,Angiopoietin-Related Protein 4,Pp1158,FIAF,NL2,Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein,Hepatic Angiopoietin-Related Protein,PPARG Angiopoietin Related Protein,Fasting-Induced Adipose Factor,Angiopoietin-Like Protein 4,Angiopoietin-Like 4,UNQ171,TGQTL,HARP
Highest Development StagePhase 2 Clinical
English NameAngiopoietin-related protein 4
Target SynonymAngiopoietin-like protein 4,Hepatic fibrinogen/angiopoietin-related protein,HFARP,ARP4,PGAR,PP1158,PSEC0166,UNQ171/PRO197,Angiopoietin Like 4,Hepatic Fibrinogen/Angiopoietin-Related Protein,Angiopoietin-Related Protein 4,Pp1158,FIAF,NL2,Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein,Hepatic Angiopoietin-Related Protein,PPARG Angiopoietin Related Protein,Fasting-Induced Adipose Factor,Angiopoietin-Like Protein 4,Angiopoietin-Like 4,UNQ171,TGQTL,HARP
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 2 Clinical

Angiopoietin-like 4 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
AN4-H5243
Human
HEK293
Human Angiopoietin-like 4 / ANGPTL4 (166-406) Protein, His Tag
Total: 1
  • 1

Angiopoietin-like 4 Background

Angiopoietin-related protein 4 (ANGPTL4) is also known as Hepatic fibrinogen / angiopoietin - related protein (HFARP), ARP4, PGAR. ANGPTL4 contains one fibrinogen C-terminal domain. ANGPTL4 is a homooligomer , and the homooligomer undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. The homooligomer unprocessed form is able to interact with the extracellular matrix. ANGPTL4 may act as a regulator of angiogenesis and modulate tumorigenesis. ANGPTL4 inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 may exert a protective function on endothelial cells through an endocrine action.

Angiopoietin-like 4 Synonyms

ANGPTL4,ARP4,FIAF,HFARP,PGAR,pp1158,Angiopoietin like 4

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
MAR001MAR001; MAR-001Phase 2 ClinicalMareas Therapeutic Services IncHypertriglyceridemia
Details
LipisensePhase 1 ClinicalLipigon Pharmaceuticals AB, Secarna Pharmaceuticals GmbH & Co KGHypertriglyceridemia
Details
A24110HeA24110He; A-24110-HePhase 1 ClinicalLipigon Pharmaceuticals ABHyperlipidemias; Hypertriglyceridemia
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland